Targeted Wharton's jelly MSC & exosome support for peripheral nerve health
Stem cell therapy for neuropathy in Istanbul, Turkey
How our Istanbul medical team led by Uzm. Dr. Cihan Bolat evaluates your nerve conduction and metabolic profile to design a tailored regenerative protocol.
Condition-specific editorial anatomy. Explanatory labels remain in accessible text.
Understanding the condition
Understanding the condition and our regenerative approach
Peripheral neuropathy damages the delicate sensory, motor, and autonomic nerve fibers that connect the spinal cord to the feet, legs, hands, and arms. When metabolic stress, diabetes, chemotherapy, or immune inflammation impairs the microscopic blood vessels feeding these nerves (the vasa nervorum) and injures their insulating Schwann cells, patients experience persistent burning or shooting pain, tingling, numbness, coldness, and unsteady balance that disrupt walking and restorative sleep.
Wharton's jelly-derived mesenchymal stem cells (WJ-MSCs) and WJ-MSC-derived exosomes are investigated in peripheral neuropathy because they address all three pillars of peripheral nerve repair: microvascular blood supply, perineural inflammation, and Schwann cell trophic support. Through targeted paracrine and vesicular signaling, WJ-MSCs and exosomes secrete potent angiogenic factors such as VEGF and bFGF to stimulate capillary microcirculation around ischemic nerves, while releasing IL-10 and TGF-β to shift pro-inflammatory M1 macrophages toward a nerve-repairing M2 phenotype. Simultaneously, they deliver essential neurotrophic growth factors—including nerve growth factor (NGF), BDNF, and GDNF—alongside regenerative microRNAs that nourish Schwann cells, support myelin sheath maintenance, improve axonal mitochondrial energy transport, and quiet hyperexcitable small pain fibers.
At our Istanbul clinic led by Uzm. Dr. Cihan Bolat, we review your EMG and nerve conduction studies, metabolic blood panels, and symptom distribution to design an individualized protocol combining targeted intramuscular/perineural administrations with systemic intravenous WJ-MSCs and exosomes. Coordinated alongside your ongoing metabolic or neurological care at home, our program aims to calm neuropathic burning and tingling, enhance protective sensation, and support steadier gait and balance.
Reviewed by: Uzm. Dr. Cihan Bolat · Reviewed · Re-review due
What happens inside the body
Key biological processes and therapeutic targets
Peripheral neuropathy is driven by microvascular ischemia of the vasa nervorum, chronic macrophage-mediated perineural inflammation, Schwann cell demyelination, and distal axonal mitochondrial exhaustion—interconnected biological mechanisms directly targeted by WJ-MSC and exosome therapy.
What our protocol aims to support
- Enhancing microvascular nerve perfusion: WJ-MSCs and exosomes release angiogenic growth factors (VEGF, bFGF) aimed at supporting the vasa nervorum capillary networks that nourish peripheral nerves.
- Calming neuropathic inflammation & fiber hyperexcitability: Immunomodulatory signaling aims to quiet inflammatory sensitization around small and large nerve fibers to support greater daily and nighttime comfort.
- Providing neurotrophic support for axons & Schwann cells: Paracrine factors such as NGF, BDNF, and GDNF alongside exosomal microRNAs aim to support Schwann cell myelin homeostasis and functional nerve signaling.
- Integrated with metabolic & cause-specific care at home: Our regenerative protocols are designed to work alongside your ongoing blood sugar management, nutritional optimization, and specialist care.
- 01
Microvascular ischemia of the vasa nervorum
Chronic hyperglycemia, vascular aging, or toxic exposure thickens the basement membrane and narrows the microscopic vasa nervorum capillaries that supply oxygen to peripheral nerve trunks, causing ischemic nerve injury in the feet and hands. Wharton's jelly MSCs and exosomes release powerful angiogenic signals—including VEGF, angiopoietin-1, and hepatocyte growth factor (HGF)—that stimulate endothelial repair and functional capillary remodeling. Restoring microvascular blood flow improves oxygenation and nutrient delivery along distal nerve pathways. Better perfusion is a critical first step in halting ischemic axonal stress.
- 02
Perineural & dorsal root inflammatory signaling
Damaged nerve fibers and infiltrating M1 macrophages release TNF-α, IL-1β, and IL-6 around peripheral axons and dorsal root ganglia, sensitizing unmyelinated C-fibers and A-delta fibers to fire spontaneously with burning, electric, or pins-and-needles pain. WJ-MSCs and WJ-MSC exosomes polarize macrophages toward an anti-inflammatory M2 repair state and release IL-10 and TGF-β into the perineural space. This immunomodulatory shift calms inflammatory sensitization of nociceptive ion channels. Quieting perineural inflammation directly supports calmer nighttime sleep and reduced burning discomfort.
- 03
Schwann cell & myelin sheath vulnerability
Schwann cells wrap peripheral axons in insulating myelin sheaths and supply essential trophic molecules, but metabolic and immune stress impairs Schwann cell function, slowing nerve conduction velocity and causing numbness and loss of balance. WJ-MSCs and exosomes deliver NGF, BDNF, GDNF, and specific regenerative microRNAs that are taken up by Schwann cells to promote survival, remyelination signaling, and extracellular matrix stability. Supporting Schwann cell health helps insulate vulnerable axons and stabilize electrical impulse transmission. Healthier nerve conduction supports clearer tactile feedback and steadier proprioception.
- 04
Axonal mitochondrial & oxidative stress
Because peripheral axons extend up to a meter from the spinal cord to the toes, they rely on continuous mitochondrial energy transport; oxidative free radicals disrupt this axonal transport and trigger distal 'dying-back' fiber degeneration. Nanoscale exosomes from Wharton's jelly MSCs carry antioxidant enzymes (such as SOD and catalase) and metabolic signaling proteins that buffer oxidative stress and support mitochondrial ATP synthesis along the axon. Protecting axonal bioenergetics helps preserve distal nerve endings in the feet, legs, and hands. Stronger cellular energy resilience supports long-term nerve maintenance.
Why regenerative medicine is investigated
Scientific rationale for Wharton's jelly MSCs and exosomes
Rebuilding the Neurovascular & Trophic Microenvironment
Peripheral nerves are living tissues with high oxygen and energy demands, supplied by a delicate network of microscopic capillaries called the vasa nervorum. In diabetic, metabolic, and toxic neuropathies, capillary loss and chronic inflammation starve long nerve axons and strip away their supportive Schwann cell insulation. Regenerative therapy targets this root biological deficit by delivering angiogenic and neurotrophic signals directly to the perineural environment. Restoring microvascular perfusion and calming macrophage inflammation gives stressed nerve fibers the biological support needed to stabilize conduction and repair.
How WJ-MSCs & Exosomes Support Axons & Schwann Cells
Wharton's jelly MSCs secrete vascular endothelial growth factor (VEGF) to nourish perineural blood vessels alongside nerve growth factor (NGF), BDNF, and GDNF, which directly stimulate Schwann cell survival and axonal sprouting. Paired with WJ-MSC exosomes, nanoscale vesicles penetrate deep into peripheral nerve sheaths and dorsal root pathways to transfer protective proteins, antioxidant enzymes, and myelin-supportive microRNAs. This signaling helps quiet spontaneous sodium-channel firing in sensitized C-fibers while supporting myelin maintenance on larger sensory and motor fibers. Together, cells and exosomes address both neuropathic pain signaling and nerve fiber resilience.
Combined Local Depot & Systemic Administration in Istanbul
Uzm. Dr. Cihan Bolat and our medical team review your EMG/NCS reports, HbA1c and vitamin panels, and symptom map before designing your protocol. By pairing systemic intravenous infusions with targeted intramuscular/perineural injections along the affected limbs, we place a concentrated paracrine depot close to damaged peripheral nerves while addressing whole-body metabolic inflammation. Every step is timed to complement your home diabetes, nutritional, or neurological care.
Our treatment approach & administration routes
How our proposed Wharton's jelly MSC and exosome protocols work
- 01
Intramuscular / Targeted Perineural WJ-MSC & Exosome Administration
Published clinical studies in peripheral neuropathy highlight the importance of placing regenerative cells and vesicles in close anatomical proximity to the affected nerve beds. Our physicians perform targeted intramuscular and perineural administrations along the lower legs, feet, or upper limbs—creating a localized paracrine depot of Wharton's jelly MSCs and exosomes near the compromised peripheral nerve trunks and their vasa nervorum capillaries. From this local depot, the biologics continuously release VEGF, NGF, BDNF, and anti-inflammatory cytokines directly into the surrounding tissue microenvironment. This targeted route is chosen to maximize local angiogenesis, Schwann cell nourishment, and small-fiber calming where distal nerves are most stressed.
Role in your protocolOur medical team determines the exact Wharton's jelly MSC and exosome combination, dosage, and administration route after evaluating your medical history and reports.
- 02
Intravenous WJ-MSC Administration
Intravenous infusion delivers Wharton's jelly MSCs throughout the systemic vasculature to address the underlying metabolic, vascular, and immune drivers of peripheral neuropathy. Circulating MSCs modulate systemic macrophage and T-cell activity, lowering blood-borne levels of TNF-α and IL-6 while supporting systemic endothelial function and microcirculation. By improving the systemic vascular and inflammatory terrain, intravenous WJ-MSCs reinforce the local repair signals occurring along peripheral nerve trunks. This dual systemic-and-local approach is especially valuable in diabetic, metabolic, and immune-mediated neuropathies.
Role in your protocolOur medical team determines the exact Wharton's jelly MSC and exosome combination, dosage, and administration route after evaluating your medical history and reports.
- 03
Intravenous WJ-MSC Exosome Administration
Intravenous WJ-MSC exosomes provide billions of nanoscale extracellular vesicles carrying neurotrophic proteins, angiogenic signals, and regulatory microRNAs throughout the microcirculation. Their small size allows them to penetrate endoneurial capillaries and dorsal root ganglia to deliver repair instructions directly to stressed Schwann cells and sensory neurons. Exosomal cargo helps reduce oxidative stress, stabilize mitochondrial function, and support axonal membrane integrity. Combining intravenous exosomes with local and systemic WJ-MSCs provides comprehensive cellular and vesicular coverage.
Role in your protocolOur medical team determines the exact Wharton's jelly MSC and exosome combination, dosage, and administration route after evaluating your medical history and reports.
- 04
Intrathecal Administration (When Clinically Indicated)
For selected patients whose neuropathy involves proximal nerve roots, lumbosacral radiculoplexus neuropathy, or central-peripheral demyelinating overlap (such as CIDP variants), intrathecal WJ-MSC administration into the cerebrospinal fluid may be incorporated after specialist neurological review. Performed with or without sedation depending on clinical circumstances, intrathecal delivery bathes the cauda equina, dorsal root ganglia, and spinal nerve roots directly in neurotrophic and anti-inflammatory factors. Our medical team determines whether intrathecal support adds clinical value based on your EMG and spine MRI findings.
Role in your protocolOur medical team determines the exact Wharton's jelly MSC and exosome combination, dosage, and administration route after evaluating your medical history and reports.
What we aim to achieve
Therapeutic objectives and functional outcomes we track
Before treatment in Istanbul, our physicians establish your clinical baseline and define realistic biological and functional objectives to track during follow-up.
- 01
Neuropathic Burning, Tingling & Nighttime Comfort
Tracking validated neuropathic pain scales, pins-and-needles paresthesias, and nighttime sleep continuity. By calming perineural macrophage inflammation and small-fiber hyperexcitability, the protocol aims to soothe burning discomfort and restore restful sleep.
- 02
Tactile Sensation & Protective Foot Awareness
Monitoring light touch, vibration sense, temperature perception, and tissue health in the feet and hands. Supporting Schwann cell myelin homeostasis and microvascular perfusion aims to help patients regain clearer sensory feedback and reduce numbness.
- 03
Balance, Gait Stability & Walking Endurance
Evaluating standing steadiness, proprioception on uneven surfaces, and comfortable walking distance alongside physical therapy. Stronger large-fiber and neuromuscular signaling helps support confident movement and reduce fall risk.
- 04
Electrophysiologic & Functional Nerve Stability
Reviewing follow-up EMG and nerve conduction velocity (NCV) parameters when repeated by your home neurologist, alongside daily functional independence. Angiogenic and neurotrophic support aims to stabilize axonal conduction and distal nerve resilience over time.
How treatment is personalized
How our medical team evaluates your records and designs your protocol
How our Istanbul medical team led by Uzm. Dr. Cihan Bolat evaluates your nerve conduction and metabolic profile to design a tailored regenerative protocol.
Medical history & reports we request
- Neurological history, symptom distribution, and underlying etiology
- EMG and nerve conduction study reports when available
- Metabolic labs including HbA1c, vitamin B12, thyroid, and renal panels
- Skin integrity, peripheral circulation, and current medication list
- Protocol planning with Uzm. Dr. Cihan Bolat to match systemic and targeted routes
Clinical suitability & protocol checks
- Any active foot infection, open ulcer, or acute vascular emergency should be treated promptly by your local medical team before scheduling travel.
- Patients continue their prescribed diabetes, metabolic, and neuropathic medications throughout their Istanbul program.
- Most neuropathy protocols are completed over a comfortable multi-day outpatient schedule in Istanbul with structured remote follow-up afterward.
What the patient journey looks like
From your first inquiry to individualized treatment in Istanbul
- 01
Contact us & share your medical reports
Reach out regarding your condition and share your medical history, diagnosis, imaging, and relevant lab reports via our secure form or WhatsApp.
- 02
Medical team evaluation & protocol design
Our medical team evaluates your records and, where clinically appropriate, develops an individualized Wharton's jelly MSC and exosome protocol.
- 03
Transparent explanation of protocol & costs
We explain the proposed treatment, specific biologics, administration routes, intended therapeutic objectives, stay timeline, and itemized costs.
- 04
Arrange treatment in Istanbul & follow-up
Review your individualized proposal, schedule your visit to Istanbul with private airport and clinic transfers, and continue with structured 1, 3, and 6-month follow-up.
2026 cost & protocol planning
Transparent Istanbul pricing tailored to your protocol
After our medical team evaluates your records, we provide a written proposal explaining the recommended Wharton's jelly MSC and exosome preparations, administration routes, intended objectives, stay timeline, and itemized costs.
For 2026 planning context, targeted exosome and local orthopedic protocols typically range from $3,500–$6,500, while comprehensive Wharton's jelly MSC and exosome programs range from $7,000–$18,000. Your exact cost is confirmed after your medical evaluation.
- Any active foot infection, open ulcer, or acute vascular emergency should be treated promptly by your local medical team before scheduling travel.
- Patients continue their prescribed diabetes, metabolic, and neuropathic medications throughout their Istanbul program.
- Most neuropathy protocols are completed over a comfortable multi-day outpatient schedule in Istanbul with structured remote follow-up afterward.
What your written treatment proposal explains
- 01
Which Wharton's jelly MSC, exosome, or combined protocol is proposed for your condition?
- 02
Which administration routes are recommended and how do they work biologically?
- 03
What are the intended therapeutic objectives and expected stay length in Istanbul?
- 04
What is the itemized cost and how does 1, 3, and 6-month follow-up work after treatment?
Evidence & important considerations
Published clinical research and important considerations
Below is a summary of published human studies, investigated mechanisms, and important limitations relevant to regenerative medicine for this condition.
01 Cell therapy for diabetic peripheral neuropathy
Open study- Product
- Umbilical cord and Wharton's Jelly mesenchymal stromal cell preparations
- Route
- Local intramuscular and systemic vascular delivery in clinical protocols
- Study design
- Systematic review and meta-analysis of clinical studies
- Finding
- Clinical studies reported improvements in neuropathic symptom scores and nerve conduction velocity parameters alongside favorable short-term safety.
- Limitation
- Study heterogeneity and sample sizes highlight the importance of combining regenerative support with consistent metabolic control and structured follow-up.
Scientific references
Clinical studies and scientific references
FAQ
Frequently asked questions about this treatment
Request Free Medical Evaluation
Begin a personalized treatment conversation with our medical team.
Share your case in confidence. Our international coordinators review every enquiry and respond within 24 hours, in your language.